Noradrenaline versus terlipressin in the treatment of hepatorenal syndrome

被引:0
|
作者
Singh, V. [1 ]
Ghosh, S. [1 ]
Chawla, Y. [1 ]
Singh, B. [2 ]
Sharma, N. [3 ]
Bhalla, A. [3 ]
Nain, C. K. [4 ]
机构
[1] PGIMER, Dept Hepatol, Chandigarh, India
[2] PGIMER, Dept Nucl Med, Chandigarh, India
[3] PGIMER, Dept Internal Med, Chandigarh, India
[4] PGIMER, Dept Gastroenterol, Chandigarh, India
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A98 / A98
页数:1
相关论文
共 50 条
  • [31] Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence
    Zhang, Jingqiao
    Roessle, Martin
    Zhou, Xinmiao
    Deng, Jiao
    Liu, Lu
    Qi, Xingshun
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (05) : 859 - 868
  • [32] Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis
    Wan, Yue-Meng
    Huang, Song-Quan
    Wu, Hua-Mei
    Li, Yu-Hua
    Yin, Hong-Jing
    Xu, Ying
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [33] Nor adrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome: A randomized controlled trial
    Sharma, Praveen
    Kumar, Ashish
    Sharma, Barjesh C.
    Sarin, Shiv K.
    HEPATOLOGY, 2006, 44 (04) : 449A - 449A
  • [34] Treatment with terlipressin as a bridge to liver transplantation in a patient with hepatorenal syndrome
    Le Moine, O
    El Nawar, A
    Jagodzinski, R
    Bourgeois, N
    Adler, M
    Gelin, M
    Cremer, M
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1998, 61 (02): : 268 - 270
  • [35] Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
    Wong, F.
    Pappas, S. C.
    Curry, M. P.
    Reddy, K. R.
    Rubin, R. A.
    Porayko, M. K.
    Gonzalez, S. A.
    Mumtaz, K.
    Lim, N.
    Simonetto, D. A.
    Sharma, P.
    Sanyal, A. J.
    Mayo, M. J.
    Frederick, R. T.
    Escalante, S.
    Jamil, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 818 - 828
  • [36] Role of Terlipressin and Albumin Combination versus Albumin Alone in Hepatorenal Syndrome
    Zafar, Shamail
    Haque, Israr
    Tayyab, Ghias Un
    Khan, Gulsena
    Chaudry, Nusrat
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S175 - S176
  • [37] Terlipressin versus noradrenalin in hepatorenal syndrome: a prospective, randomised, unblinded study
    Goyal, O.
    Sehgal, N.
    Puri, S.
    Sidhu, S. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A76 - A76
  • [38] Terlipressin for hepatorenal syndrome: opportunities and challenges
    Singal, Ashwani K.
    Jalan, Rajiv
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (02): : 104 - 106
  • [39] Terlipressin for Type 1 Hepatorenal Syndrome
    Terbah, R.
    Gow, P.
    Sinclair, M.
    Testro, A.
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (08) : 2454 - 2455
  • [40] Terlipressin for Type 1 Hepatorenal Syndrome
    R. Terbah
    P. Gow
    M. Sinclair
    A. Testro
    Digestive Diseases and Sciences, 2020, 65 : 2454 - 2455